Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review
- PMID: 33519144
- PMCID: PMC7836964
- DOI: 10.1016/j.jksus.2020.101286
Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review
Abstract
In recent years increased attention is focussed on microorganisms inhabiting the digestive system that provides prophylactic and therapeutic benefits to the host. After Metchnikoff exposed the secret behind Bulgarian peasants' extended longevity, a graze to incorporate the responsible microbes in functional food emerged. Then interest towards microbe-rich food went to the vegetative phase for some time, but now a renaissance to engage these wonder microbes in the healthcare sector is increasing. With a new definition, probiotics, these good microbes have been widely applied in different types of products, either as pharmaceuticals, nutritional supplements, or foods. Probiotics, a significant source in functional dairy products, claims diverse roles such as improving intestinal tract health, enhancing the immune system, synthesizing and enhancing the bioavailability of nutrients, reducing symptoms of lactose intolerance, decreasing the prevalence of allergy in susceptible individuals, and reducing the risk of certain cancers. In the recent COVID-19 issue, searches are going fast to use probiotics as vaccine carriers, dysbiosis balancer, and immunity booster. The high expectation from probiotics expanded the development of bioengineered probiotics as new-generation probiotics. From the animal model and in vitro studies, the probiotic intervention is extrapolated to innate and adaptive immunity inducer against SARS viral infections. The possibility of using it as prophylactic and therapeutic agents in COVID-19 is explored. However, its significant activity against corona virus-induced respiratory syndromes is questioned by a few researchers also. The emerging citations on the research approach and meta-analysis of probiotic intervention against the re-emerging pandemic viral attack on the respiratory and gastrointestinal domains need to be analyzed in this context. As it is essential to understand the reality of recent experimental outcomes in the probiotic approach towards SARS-CoV-2 prevention, management, and control, the recent publications were focused on this review.
Keywords: Lactobacilli; MERS; Probiotics; SARS; SARS-CoV-2.
© 2020 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Ahmed-Hassan H., Sisson B., Shukla R.K., Wijewantha Y., Funderburg N.T., Li Z., Hayes D., Jr., Demberg T., Liyanage N. Innate immune responses to highly pathogenic coronaviruses and other significant respiratory viral infections. Front. Immunol. 2020;11:1979. doi: 10.3389/fimmu.2020.01979. - DOI - PMC - PubMed
-
- Al-Thubiani A.S., Ahmed Khan M.S. The probiotic properties of date palm (Phoena declycifera L) seeds in stimulating probiotic Lactobacillus. JPAM. 2017;11(4):1675–1686. doi: 10.22207/JPAM.11.4.05. - DOI
-
- Ang L.Y., Too H.K., Tan E.L., Chow T.V., Shek L.P., Tham E.H., Alonso S. Erratum to: antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines. Virol. J. 2016;13(1):186. doi: 10.1186/s12985-016-0633-0. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous